You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
McKesson
Johnson and Johnson
Dow
AstraZeneca

Last Updated: March 31, 2020

DrugPatentWatch Database Preview

Litigation Details for Allergan, Inc. v. Lupin Ltd. (E.D. Tex. 2011)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Allergan, Inc. v. Lupin Ltd. (E.D. Tex. 2011)

Docket   Start Trial Date Filed 2011-12-30
Court District Court, E.D. Texas Date Terminated 2013-11-07
Cause 35:271 Patent Infringement Assigned To James Rodney Gilstrap
Jury Demand Both Referred To
Parties AKORN INC; ALCON LABORATORIES, INC.; ALCON PHARMACEUTICALS, LTD.; ALCON RESEARCH, LTD.; ALLERGAN SALES, LLC; ALLERGAN, INC.; APOTEX CORP.; APOTEX, INC.; DAVID FOLSOM; DAVID MANSPEIZER; FALCON PHARMACEUTICALS, LTD; LUPIN LTD.; LUPIN PHARMACEUTICALS, INC.
Patents 8,008,338; 8,207,215; 8,377,982
Attorneys Aaron S Lukas; Barry P Golob; Corrin Nicole Drakulich; Darrell Glyn Dotson; David A. Manspeizer; Deanna Jean Reichel; Deron R Dacus; Ellen A Scordino; Eric Hugh Findlay; Gauri M Dhavan; Grace Lillian Wang; Jack Wesley Hill; James F Hurst; Jonathan Elliot Singer; Joseph T Jaros; Juanita Rose Brooks; Kathleen B Barry; Kerry B McTigue; Laura Whitney Lee; Luke T Shannon; Malaika O Tyson; Paul J Molino; Raymond C Perkins; Richard T Ruzich; Ryan Blaine Brown; Shannon Marie Dacus; Tamara D Fraizer; Thomas J Wimbiscus; Timothy F Peterson; W Chad Shear; William A Rakoczy; William Blake Coblentz; William Ellsworth Davis , III
Firms Cozen O'Connor Chicago; Fish & Richardson - Redwood City; Fish & Richardson PC - Boston; McAndrews Held & Malloy; Rakoczy Molino Mazzochi Siwik; Squire Patton Boggs (US) LLP Palo Alto; WILMER, CUTLER, PICKERING, HALE AND DORR, LLP New York; Winston & Strawn, LLP (Chicago)
Link to Docket External link to docket
Small Molecule Drugs cited in Allergan, Inc. v. Lupin Ltd.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Allergan, Inc. v. Lupin Ltd. (E.D. Tex. 2011)

Date Filed Document No. Description Snippet Link To Document
2011-12-30 1 infringement of United States Patent No. 8,008,338 (“the ’338 patent”) under 35 U.S.C. §§ 271(a), (b… stated that the ’338 patent is invalid and that claims 6-9 of the ‘338 patent will not be infringed … 314.95 that the ’338 patent is invalid and that claims 6-9 of the ‘338 patent will not be infringed …FDA, in which they identified the ’338 patent as one of the patents covering the approved formulation of…FDA, in which they identified the ‘338 patent as one of the patents covering the approved formulation of External link to document
2013-06-07 107 regarding United States Patents No. 8,008,338 (''the '338 patent"), No. 8,207,215 (&…#39;'the '215 patent"), and No. 8,377,982 ("the '982 patent") (collectively,…during prosecution of the '338 patent, as well as the related patents, further show that those of skill…collectively, the patents-in-suit). 8. In expressing opinions on legal issues, I have applied… ordinary skill in the art for purposes of the patents-in- suit would have been a person with a scientific External link to document
2013-08-21 124 concerning U.S. Patent Nos. 8,008,338 (“the ‘338 patent), 8,207,215 (“the ‘215 patent”); and 8,377,982… in the patents in suit, including claims of the ‘215 patent and claim 21 of the ‘982 patent, Defendants…subsequent patents. That is not surprising, as frequently the scope of patent claims in a patent family…terms of the 338 and 982 patents. There are no disputed terms for the 215 patent. Within thirty (30) days… “[a] claim in a patent provides the metes and bounds of the right which the patent confers on the patentee External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Medtronic
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.